Chemistree Technology Inc.

(CSE:CHM.CN) (OTCQB:CHMJF)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

Mainstream CBD Acceptance Being Driven By Boomers and Millennials

FN Media Group Presents Potstocknews.com Market Commentary

 

New York, NY – May 7, 2019 – Sales of cannabidiol (CBD) oil are dramatically rising across North America, as its availability on mainstream shelves caters to growing health, wellness, and beauty markets. Much of this growth is being driven at two ends of the age spectrum, as hemp-based CBD is becoming more and more popular among both baby boomers and millennials. As the health benefits of CBD continue to be studied, the economic benefits are becoming apparent to the producers of CBD products including Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), Canopy Growth Corporation (NYSE:CGC) (TSX:WEED), HEXO Corp. (NYSE:HEXO) (TSX:HEXO) and CannTrust Holdings Inc. (NYSE:CTST) (TSX:TRST).

 

The entire sector started to truly take off after the signing by President Donald Trump of the 2018 Farm Bill back in December. Following the bill’s legalization of hemp farming nationwide, many companies much like Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) have ramped up their CBD operations. Chemistree recently acquired a stake in The Physician’s Choice CBD—developers of nine hemp-derived full spectrum CBD products.

 

Hemp-based CBD products are making their way to the forefront, including with the FDA, which is itself moving towards a loosening of CBD’s regulatory shackles. The result has been a positive shift in the CBD hemp oil market, which data compiled by analysts at Transparency Market Research have indicated to project growth from $950 million in 2017 to $2.5 billion by 2026.

 

However, a new study by CBD Marketing in Chicago showed that the market has all but erased the generation gap, between baby boomers, Gen X, and millennials. The study analyzed 1.3 million US social media posts and other public comments between Jan. 1, 2018 to Jan. 1, 2019. At the two ends of the spectrum, baby boomers (54-72 y/o) and millennials (22-37 y/o) each generated 41% of the posts, while Gen Xers (38-53) represented 18%.

 

Both boomers and millennials are seeing prominent figures catering to their demographics in favor of CBD. For boomers, it was announcements such as Martha Stewart’s endorsement deal with Canopy Growth Corporation (NYSE:CGC) (TSX:WEED), and legendary PGA golfer Greg Norman’s brand coming out with its own CBD personal care products.

 

With millennials, it’s news if Kim Kardashian throwing a CBD-themed baby shower, and American Horror Story star Emma Roberts posting on Instagram about her favorite products that include CBD-infused bath tonics.

 

Methods of delivery of CBD are numerous. Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) saw its stock price rise nearly immediately after acquiring the remaining shares of Hempco Food and Fiber, further capitalizing on the CBD trend.

 

HEXO Corp. (NYSE:HEXO) (TSX:HEXO) went the beverage route through a major deal with major beer bottlers, Molson Coors in Canada. The company also hinted that it could launch its CBD-infused products in as many as eight states where it believes they’ll be legal. HEXO also markets its popular Elixir CBD MCT Oil Oral Spray, which presents a quick and convenient way to ingest CBD.

 

Also coming in convenient delivery forms is CannTrust Holdings Inc. (NYSE:CTST) (TSX:TRST) which recently released three new products: High Dose and Low Dose CBD Capsules, and High Dose CBD Drops.

 

Capturing the CBD Buzz on Social Media

 

Within the CBD Marketing study, what was discovered was how people talk about CBD, giving the market more insight on what’s the most appealing among CBD’s alleged benefits.

 

Over 280k posts talked about pain management, including chronic pain from cancer, inflammation, joint pain, etc. Another +250k posts focused on CBD’s effect on stress relief, anxiety, insomnia, and general depression. When talking about mental health benefits, 90% of the posts about CBD’s efficacy were positive.

 

There’s also a growing amount of talk regarding CBD’s role in health and beauty, with over approximately 140k posts, specifically talking about treating acne and other skin conditions such as eczema, rashes, psoriasis, slowing down aging, and reducing inflammation related to skin conditions. Lastly, there was a growing amount of talk regarding pet care and treatments, with roughly 100k posts about the subject.

 

All three groups had more than 86% positive responses in the posts, showing an overwhelmingly accepting crowd.

 

Leveraging Positive Medical Opinions

 

Of the two most talked about subjects, the Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) stake acquisition of The Physician’s Choice CBD brings products appealing to the top three CBD social media topics—pain management, stress relief/anxiety, and health and beauty.

 

The Physician’s Choice CBD group has already developed a suite of nine full-spectrum, hemp-derived CBD products ranging from pain/inflammation management to sleep and wellness supplements. Helming the company are Dr. Julian Grove, MD, and Dr. Peter Kubitz, D.O. with over 15 years in private practice, with the first-hand experience in treating patients suffering from chronic pain. The integration of extensive physician clinical experience combined with exhaustive expertise in the cannabis industry has led to the creation of The Physicians Choice CBD brand.

 

“Managing various pain syndromes with medications that do not exacerbate severe medical conditions and behavioral risk factors is an ongoing challenge for medical professionals,” said Dr. Grove. “This has been a driving force in the development of a product line of cannabidiol products, aiding in the management of specific pain syndromes and improve a sense of well-being.”

 

In its first quarter of sales (ending in Jan. 2019), the company already booked $150,000 in sales.

 

“This investment in The Physician’s Choice CBD is a great opportunity for Chemistree,” said President of Chemistree, Karl Kottmeier. “Dr. Grove and Dr. Kubitz are board certified practicing physicians with training at Harvard and the Mayo Clinic, specializing in pain management. Their collective education and practical experience is industry-leading and their commitment to the health of their patients and to developing real solutions to pain management with cannabidiol-based supplements is truly inspiring. The investment we are making into PCCBD gives us exposure to an entirely new industry.”

 

New Forms of CBD Delivery Methods

 

The market awaits the development of CBD-infused non-alcoholic beverages from companies like Canopy Growth Corporation (CGC) (WEED) and HEXO Corp. (HEXO), who have signed partnership deals with beverage giants Constellation Brands, Inc. and Molson Coors Brewing Company respectively.

 

However, Canopy has also branched out into pet care products, which likely will be launched in the near future, through a high-profile partnership with baby boomer celebrity icon Martha Stewart. HEXO has already established its CBD presence with conventional delivery methods, such as sprays and drops.

 

CannTrust Holdings Inc. (CTST) (TRST) is expanding its CBD product lines, with the addition of three new products, which include High Dose CBD Oil Capsules, a Low Dose version, and High Dose CBD drops. CannTrust also has planned a wide range of CBD-infused drinks, including Brewbudz, a single-serve cannabis-infused coffee and tea brewing pod technology, with a patent in North America and Australia.

 

Increasingly focusing more upon the medical marijuana community, Aurora Cannabis Inc. (ACB) has begun to turn its attention to hemp production. Hemp crops provide a low-cost source of CBD, once extracted, which Aurora has signaled it will pursue. The company has begun working with (and owns a stake in) soft-gel capsule producers Capcium.   Aurora also flirted with a partnership with The Coca-Cola Company, before talks were officially ended. However, the talks showed a possible in-road for mainstream beverages from the company in the future.

 

For a FREE research report on Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF), visit www.potstocknews.com

 

Disclaimer:  Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

 

The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of Chemistree Technology Inc.

 

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PSN and FNM undertake no obligation to update such statements.

 

Media Contact:

FN Media Group, LLC

info@financialnewsmedia.com

+1(561)325-8757

Source: Potstocknews.com

Distinct Regional Advantages Emerging for Pacific Northwest in Blossoming Cannabis Sector

New York NY – December 11, 2018 – Distinct advantages are appearing in each region of the emerging cannabis market. Leading the pack are the state of California, and the entire country of Canada, which each have their own favorable regulations to adhere to for a growing class of ambitious cannabis companies that include Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF),Hexo Corp. (OTC:HYYDF) (TSX:HEXO), Organigram Holdings Inc. (OTC:OGRMF) (TSX.V:OGI), Supreme Cannabis Co. (TSX-V:FIRE) (OTC:SPRWF),and iAnthus Capital Holdings Inc. (CSE:IAN) (OTC:ITHUF).

 

Legalization takes many forms. For instance, while Canadian dispensaries are opening nationwide, marketers of these new products are restricted in how they conduct their branding—ie. only boring generic labels are allowed. Whereas, the similarly large population of California are being exposed to all types of new products, brands, and labels.

 

The Golden State’s branding advantage has given companies such as Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) the impetus to set up shop in California while importing established brands in from other parts of the Pacific Northwest. The company recently solidified a land purchase of 9.55 acres in California’s prominent Desert Hot Springs Cannabis Cultivation Zone.

 

Upon the commencement of production from the Desert Hot Springs Cannabis Cultivation Zone, it appears that getting the product into the hands of customers should become even easier than it was before. Californian regulators most recently stated that marijuana deliveries can be made anywhere in the state—even in locales that ban cannabis.

 

The proposed regulations become permanent next month after state lawyers finish reviewing them. However, the proposals also come with their potential drawbacks, including a ban on permit holders partnering with unlicensed partners, which industry supporters said will stifle growth. They also continue to allow farmers to receive an unlimited number of permits to grow.

 

With the recently acquired global brand and marketing rights for the Washington-based Sugarleaf brand in hand, Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) is seemingly poised to make a big leap across state lines.

 

California’s Land of Opportunity

 

For Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) establishing Sugarleaf in California is a primary objective. The first move for the company is the latest strategic collaboration recently launched with a Humboldt County-based cannabis processing company that holds a “Type 6: Non Volatile Solvent Extraction” license from the State of California. The processor uses Apeks supercritical CO2 extraction to produce cannabis oil, terpene profiles and other products on behalf of cannabis cultivators, other manufacturers, and processors throughout northern California.

 

Once extraction has taken place, the sky’s the limit on the choice of products, as the cannabis flower can be incorporated into edibles. Edibles spending in Canada and the US surpassed $1 billion in 2017 and is projected to grow to more than $4.1 billion by 2022.

 

As the market shakes out the poseurs from the players, consumers are at this very early stage beginning to align themselves with their favorite products—a decision that could solidify a relationship that could last years. Quality, availability, and that “it” factor goes into every buying decision.

 

Whether the customer is seeking something they’ll be buying on a regular basis, or pulling out their wallets and seeking the “champagne of cannabis” which is being sold for upwards of $800 per ounce—It’s up to cannabis companies to give the customer what they want.

 

Banking on the Pacific Northwest Branding Advantage

 

Branding and marketing new products require finesse and capital. Now many are looking to the Pacific Northwest to be the central launch pad for new cannabis brands and products.

 

The region has had disproportionate success in brand building, having spawned such notable giants as Nike, Microsoft, Starbucks, and Amazon. Should brands such as Washington-based Sugarleaf take the next step in terms of name-recognition, its Pacific Northwest origins won’t soon be forgotten.

 

With the cannabis market emerging as potentially a new competitor (or compliment) to coffee and other versions of life’s pleasures, a unique opportunity is at hand. It’s up to companies to get out ahead of the herd early and seize an early-mover advantage as soon as possible.

 

Chemistree Technology Inc.’s (CSE:CHM) (OTC:CHMJF) strategic move into California represents this type of advantage—despite the state’s already booming cannabis sales. In 2017, before recreational marijuana even became legal on January 1, 2018, California’s cannabis spending hovered near $3 billion in 2017. By 2022, that figure is expected to soar to $7.7 billion.

 

Banking on the Pacific Northwest Branding Advantage

 

As the new era of legalization across all major markets comes closer to reality, cannabis companies are at this point staking valuable ground. Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) is gearing up for a big move, now with operations in both Washington State and more importantly, California.

 

Potential new business initiatives for the company include adding key industry people in sales positions in Washington and California, developing a proprietary CBD-focused line of products and most importantly expanding the Company’s presence outside of Washington and California to other states where opportunities exist in the rapidly growing cannabis industry.

 

When his company announced its California land acquisition in November, Chemistree president Karl Kottmeier stated, “This is a great purchase for Chemistree. I am pleased to report that our highly-experienced team in California has begun working on this exciting project. We are buying a site that already has much of the Conditional Use Permit application process well underway.”

 

Now in the process of addingkey people to theChemistreeCalifornia Team, the company is currently focused on product development, biomass sourcing and sales, and marketing planning.

 

Upon acquiring the global rights for Sugarleaf and officially entering the California market, Kottmeier stated, “I am grateful to our tremendous team of advisors in California who are helping us access a market that is expected to exceed $5.1 billion next year. Sugarleaf is a high quality, flower-based product line in Washington state and now, working closely with our new processor partner in Humboldt, we will be able to develop and produce Sugarleaf manufactured products as well as flower products in the world’s sixth largest economy – the massive California market.”

 

The company’s plans for the Desert Hot Springs Cultivation Zone property includes the development of a greenhouse cultivation facility at the site that includes two separate cultivation buildings totaling 127,960 square feet and an additional 119,960-square-foot building intended for warehousing and processing facilities. Fully constructed, a facility of this size has the potential to produce approximately 50,000 pounds of cannabis flower per year.

 

Kottmeier added in the company’s most recent corporate update, “Our submission to the City of Desert Hot Springs is advancing through the regulatory process and our most recent update from our contractor has provided us with the good news that due to a rework of our plans by the City Engineer, we have an unexpected savings of approximately $500,000 to the project budget. We are confident that our submission will be successful and we are looking forward to working with the City of Desert Hot Springs going forward.”

 

Opportunities in Other Regions

 

Management at Hexo Corp. (OTCPK:HYYDF) (TSX:HEXO) is beaming, fresh off of hauling in two prizes at the 2018 Canadian Cannabis Awards. The company’s flagship Hydropothecary by HEXO took home Cannabis Product of the Year, while its peppermint medical cannabis oil sublingual spray “Elixir” won them the Innovation of the Year award. In terms of innovation, the market’s eyes are still on the Quebec-based company, in the wake of its deal signed with Molson Coors, which will likely lead to new beverage based products in the coming years.

Prior to its recent price drop, it looked as if Organigram Holdings Inc. (OTCQX:OGRMF) (TSX.V:OGI) could be the next cannabis company to make the jump onto the NYSE. However, the Moncton-based company is continuing to keep its focus on the Canadian market first and foremost. Most recently, Organigram obtained a $10 million loan from Farm Credit Canada to continue to expand its Moncton campus. The scheduled expansion is projected to increase the company’s target production capacity by 62,00kg per year and 89,000kg per year, with the additional state-of-the-art grow rooms coming online in April and August of 2019, respectively.

While refraining from launching in the United States, Supreme Cannabis Co. (TSX-V: FIRE) (OTCQX: SPRWF) recently indicated another move into international markets through a deal with a prominent cannabis tastemaker. Globally-recognized recording artist Wiz Khalifa and his global regulated cannabis brand Khalifa Kush Enterprises (KKE), just inked a deal with Supreme, launching an international partnership (excluding the US) to develop and launch a lineup of premium cannabis products. Supreme Cannabis and KKE will work to develop and commercialize a product lineup that is expected to include pre-rolls, extracts, capsules, and cannabis oils to be sold by Supreme Cannabis under the KKE brand.

 

Unlike Supreme, iAnthus Capital Holdings Inc (CSE:IAN) (OTCQX:ITHUF) is entirely focused on the United States. The New York-based company owns and operates licensed cannabis cultivation, processing, and dispensary facilities throughout the USA. At the moment, iAnthus is patiently waiting for the finalizing of the transformative acquisition of MPX Bioceutical (OTC:MPXEF) from October. The combined entity is positioned to build out its multi-state business model in the US cannabis market, with a combined market capitalization of over $600 million.

 

For a FREE research report on Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF), visit potstocknews.com.

 

 

Disclaimer:  Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

 

The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated forty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of Chemistree Technology Inc.

 

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PSN and FNM undertake no obligation to update such statements.

 

Media Contact:

FN Media Group, LLC

info@financialnewsmedia.com

+1(561)325-8757

Source: Potstocknews.com

Early Winners Emerging in American Cannabis “Green Rush”

FN Media Group Presents Potstocknews.com Market Commentary

 

New York NY – December 6, 2018 – Canada is now officially the largest legal recreational cannabis market in the world, and Americans are starting to feel the pressure. Numerous recent events have indicated that America’s longstanding cannabis prohibition could be on its last legs. These signals have sparked optimism for American cannabis companies such as Chemistree Technologies Inc. (CSE:CHM) (OTC:CHMJF) that have established a strong presence in cannabis-friendly states such as Washington and California. Notable cannabis companies outside the United States that may benefit from American cannabis legislation include Harvest One Cannabis (OTC:HRVOF) (TSX.V:HVT), WeedMD Inc. (OTC:WDDMF) (TSX.V:WMD), Namaste Technologies Inc. (OTC:NXTTF) (TSX.V:N) and CannTrust Holdings Inc. (OTC:CNTTF) (TSX:TRST).

 

In October, the U.S federal government announced it was seeking public opinion on a possible reclassification of cannabis. A recent poll also found that 62 percent of Americans support the legalization of cannabis. Most recently, the resignation of Attorney General and cannabis opponent Jeff Sessions was seen as a positive development for the cannabis industry.

 

Taken together, these developments indicate that America’s strict federal policies on cannabis at the federal level could potentially undergo a historic reversal that would legitimize an industry that is already growing at an impressive rate. This newfound optimism has already brought significant attention to American cannabis companies that have a running head-start on this new potential industry such as Chemistree Technologies Inc. (CSE:CHM) (OTCQB:CHMJF).

 

In Canada, a similar situation occurred during early legislation discussions with many companies securing significant tactical advantages. If legalization plays out across the U.S., as it has in Canada, American cannabis company valuations could rise exponentially in the coming years. In the year before legalization in Canada, cannabis stock prices in the U.S increased up to 150 percent. American companies getting a foothold before prohibition lifts may see similar trends.

 

Building Brands Before Cannabis Prohibition Ends

 

While many American cannabis companies acquired infrastructure in 2018, some went even further and built and marketed their own brands. For example, Chemistree (CSE:CHM) (OTCQB:CHMJF), acquired Washington State cannabis brand Sugarleaf – a well-known high-end cannabis brand with two consecutive Cannabis Cup awards under their belt from 2014 and 2015.

 

Sugarleaf produces a number of award-winning strains, such as White 99 – a high THC strain consumer favorite. Under Chemistree, Sugarleaf now has a market reach of over fifty retail stores in Washington state.

 

Building on this momentum, Chemistree recently announced a strategic collaboration with a Northern California processing facility in a bid to bring their Sugarleaf brand to the lucrative California market. Earlier, the company purchased nearly 10 acres for cannabis cultivation in California for just over $1.2 million. The company hopes to ultimately continue this approach to expand into new jurisdictions across the country where legal cannabis processing and product development are in their formative stages

 

This speaks to the speed the American cannabis industry is moving at. Chemistree (CSE:CHM) (OTCQB:CHMJF) is an example of a company that is already securing infrastructure and building brands. If legalization does occur it may prove difficult for new companies to enter what is likely to be a fairly mature market with significant competition.

 

Companies like Chemistree are actively replicating their approach in early markets, such as Washington and California, in other legalized states. With cannabis currently legal in thirty-three states plus Washington, DC, for medical use, and in ten states plus Washington, DC, for recreational use, it’s quite possible that some of these early movers may have a very significant national presence by the time potential legalization occurs.

 

Acquisitions, Strategic Partnerships, And Vertical Integration

 

As an early-stage industry, the American cannabis industry is filled with news stories of acquisitions, strategic partnerships, and companies maneuvering to become vertically integrated players in the industry.

 

Chemistree (CSE:CHM) (OTCQB:CHMJF) is an example of a company utilizing all three of these strategies. In addition to their acquisition of cannabis brand Sugar Leaf, the company has recently made a large financial investment into Pasha Brands, a well-established and vertically integrated brand in Canada.

 

This investment expands on Chemistree’s (CSE:CHM) (OTCQB:CHMJF) efforts to become a vertically integrated competitor in the cannabis industry, and provides the company with strategic connections into the lucrative BC cannabis marketplace for their Washington and California assets.

 

Pasha Brands owns the largest licensed retail chain in B.C. and their network of craft producers under the BC Craft Supply Co. This provides Chemistree (CSE:CHM) (OTCQB:CHMJF) access to premium strains from the network of craft producers in the BC Craft Supply Co.

 

This strategic investment is an example of an early cross-border partnership that may become much more common as American cannabis companies look to leverage the assets of well-established Canadian cannabis companies, and Canadian cannabis companies look to secure entry into the potentially larger American cannabis market.

 

This vertical approach to market expansion is providing companies such asChemistree (CSE:CHM) (OTCQB:CHMJF) with a stable platform for national growth, and possible future global expansion. As the national conversation on American cannabis heats up, the industry is likely to see more vertical integration, acquisitions, and strategic partnerships occur as companies scramble to become major players in this potential 23.4 billion dollar industry.

 

Major Players In North American Cannabis

 

Namaste Technologies Inc. (OTCQB:NXTTF) (TSX.V:N) – Aiming to become the ‘Amazon of Cannabis’, Namaste Technologies Inc. is a Canadian cannabis company focusing on the retail side of the cannabis sector. The company has applied for a “sales-only” license with the Canadian government, which could establish Namaste as a leading distributor in the international cannabis space. The company currently sells vaporizers and cannabis smoking accessories in 20 different countries across the world, but hopes to expand to offer different strains of cannabis in the future as well.

 

WeedMD Inc. (OTCQX:WDDMF) (TSX.V:WMD) – WeedMD Inc. is a Canadian licensed producer operating two cannabis greenhouses in Ontario. Together the company’s two facilities contain 70,000 square feet of licensed grow space, which the company hopes to expand to 500,000 square feet by the end of 2018. WeedMD has secured a distribution partnership with Shoppers Drug Mart, which is expected to provide the cannabis producer with optimal distribution through the pharmacy’s extensive network of stores and online retail infrastructure.

 

CannTrust Holdings Inc. (OTC:CNTTF) (TSX:TRST) – CannTrust Holdings Inc. is a federally-regulated licensed producer focusing on the medical and pharmaceutical segments of the Canadian cannabis industry. The company operates a 50,000 square foot hydroponic facility to support its 430,000 square foot greenhouse operation in Ontario. Recently CannTrust was named the Best Licensed Producer at the 2018 Canadian Cannabis Awards, where the company also took home the prize for Top Sativa Flower (OG Kush) and Top Hybrid Flower (Blueberry Kush).

 

Harvest One Cannabis (OTC:HRVOF) (TSX.V:HVT) – Harvest One is an international cannabis company with a diverse portfolio of cannabis-based ventures. The company has three wholly-owned assets including licensed producer United Greeneries, medical CBD brand Satipharm, and CBD-based sleep aid Dream Water. Harvest One’s collection of assets has enabled an effective international business strategy, catering to markets based on local rules and regulations concerning cannabis.

 

For a free research report on Chemistree (CSE: CHM) (OTC:CHMJF), visit potstocknews.com

 

 

Disclaimer:  Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

 

The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated forty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of Chemistree Technology Inc.

 

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PSN and FNM undertake no obligation to update such statements.

 

Media Contact:

FN Media Group, LLC

info@financialnewsmedia.com

+1(561)325-8757

Source: Potstocknews.com

California’s Bigger, Flashier Cannabis Market Set to Outpace Canadian Market

FN Media Group Presents Potstocknews.com Market Commentary

 

New York NY – December 4, 2018 – A divide is already happening in these early days of cannabis legalization in major markets such as Canada and California. Suppliers are jockeying for position within the hearts and minds of a growing consumer base, emphasizing the need to establish brand recognition, with pushes coming from companies such as Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF),MedMen Enterprises Inc. (CSE:MMEN) (OTC:MMNFF),Curaleaf Holdings Inc. (CSE:CURA)(OTC:CURLF), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ,and KushCo Holdings, Inc. (OTC: KSHB).

 

Regulatory challenges in Canada that don’t exist in California are likely to cause a branding gap, with the advantage going to the west coast state. Unlike in California where customers are greeted with colorful displays, hip brand names, and a plethora of products, Canadian consumers must settle for a much more subdued and humdrum buying experience.

 

Legally, Canadian cannabis companies and dispensaries can’t lure customers with flashy designs. Health Canada, the government arm overseeing packaging regulations for cannabis, wanted to approach packaging from a health and safety perspective as opposed to a revenue-generating perspective—which practically means branding is officially illegal.

 

Meanwhile, in the US, companies such as Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) can openly sponsor high-profile events such as the recent High Times ‘Biz Bash’ party, featuring celebrity rapper 2 Chainz during the MJBizCon Conference and Expo held in Las Vegas. The company’s involvement with the event was part of an aggressive marketing and sale campaign to publicize the launch of the new website of its flagship brand, Sugarleaf.

 

Jeremy Deichen of Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) commented, “it [was] our pleasure to team with our friends at High Times to pull off this amazing event. In working with them over the years with ‘Growing Exposed’ we have learned that they are truly the masters at getting eyeballs on what is new and fresh in the industry”.

 

The California Advantage

 

When Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) partnered with the Washington-based Sugarleaf brand back in May, it did so with the expressed intent to more than double the reach of the product line by the end of 2018, and to quadruple it through 2019. Part of that plan included a strategic entry into California, which was further solidified with the company’s land purchase of 9.55 acres in California’s prominent Desert Hot Springs Cannabis Cultivation Zone.

 

The move into California is significant, given the size of the market, and the blue-sky potential still yet to be realized in the state. Cannabis spending in California already hovered near $3 billion last year, prior to recreational marijuana officially becoming legal on January 1st. By 2022, the market is expected to soar to $7.7 billion.

 

However, the overall total output of the marijuana industry in the state is projected to be nearly double that, with total economic impact (going beyond direct spending only) estimated to be nearly $15 billion in the next four years.

 

With its population of nearly 40 million people, California is only slightly more populated than all of Canada at 39 million people. Yet, California alone has a higher peak sales potential than all of Canada, and that’s even with the federal government maintaining its Schedule I classification on the drug.

 

How is California so advantaged? For starters, selection for Canadian customers is much more limited, and not only because of a lack of packaging. Canadians so far can only legally purchase flower, seeds, plants and oil only, whereas Californians can get all those, plus edibles, concentrates, topicals, beauty products, infused beverages and more.

 

Add on top an ideal growing climate, that can reduce per-gram production costs, and California is built to be the hub of the US cannabis sector.

 

According to a newly released report from the Bank of Montreal, the global cannabis market could be worth $194 billion in seven years. Analysts at Bank of Montreal believe that additional countries will fully legalize marijuana, including the United States and many (if not all) European Union countries in the future.

 

If all 28 countries in the EU were to greenlight cannabis, it could lead to a $30 billion medical marijuana market and a whopping $68 billion adult-use market. Legalization in the US would mean up to $19 billion in annual medical pot sales and a further $49 billion from the recreational side of the equation.

 

With its already $3 billion in contributions, California is a global leader in the cannabis sector, with plenty of room still to grow.

 

California As a Launch Pad

 

The Californian advantage in the cannabis sector is pronounced, which is why Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) is using the state as a launch pad for the assets it’s acquiring.

 

While the legalization of adult-use recreational marijuana didn’t officially begin until January 1, 2018, medical marijuana has been in place for years.

 

Chemistree Technology Inc. has seized upon its own California advantage. Built upon a team of executives and advisors with experience in the cannabis industry across multiple markets, the company is poised for using California as a hub.

 

The company has already acquired 9.55 acres in California’s prominent Desert Hot Springs Cannabis Cultivation Zone. The property can support a total of three sites containing cultivation and processing buildings, totalling approximately 205,000 sq ft, based on the municipality’s regulations.

 

Having an alliance with the successful brand Sugarleaf, which has already been cultivating and processing cannabis products in Sedro Woolley, Washington, Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) is paving the way for an expansion.

 

Branding efforts are already underway with Sugarleaf, which has already established itself as a quality brand with prominent marketing leading the way. Among the team getting the word out will be advisor Jeremy Deichen, who brings over 20 years of cannabis industry experience in cultivation, processing, sales, branding, and marketing. Deichen is the creator of the Growing Exposed series which is distributed by the cannabis industry’s largest media publication, High Times.

 

Vertically integrated, Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF) is now primed and ready to begin establishing its California operations, through clever branding of Sugarleaf and other assets, commencing development on the Desert Hot Springs facilities, as well as expanding into Northern California with its joint venture processing facility. The company is currently seeking capital to expand locations in the state and its service offerings.

 

Further California Offerings

 

Leading retailers MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) has seen sales in California exceed expectations. The bulk of the company’s sales come from California, with eight stores in the state (including four in Los Angeles), with 92% of its $20.6 million in fiscal Q4 sales. For the most part, growing demand in California is mostly responsible for MedMen’s revenue increasing 44% from the prior quarter.

 

Going in another direction into Canada, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON)has a deal with MedMen to offer the MedMen brand into Canada. However, Cronos itself has been working on its own branding, even though its main consumer base is in Canada. Back in September, Cronos Group launched its second cannabis brand for the domestic recreational market, called Spinach™. The branding idea was to allow consumers in Canada to purchase high quality Spinach™ “without the fear of persecution for their love of beautiful green plants.”

 

Capitalizing on California’s regulatory packaging requirements, KushCo Holdings, Inc. (OTCQB: KSHB)provides companies with a trusted supplier. The specialized packaging provider has benefitted from California’s rising sales. KushCo’s own sales soared 171% year over year to $51 million last fiscal year.

 

While not currently operating in California, Curaleaf Holdings Inc. (CSE:CURA) (OTCPK:LCURLF) is steadily expanding into new markets. The most recent expansion was the opening of its 5th retail location in California-neighboring Arizona. However, with the launch of its new line of premium hemp-based CBD products called Curaleaf Hemp, Curaleaf products could eventually be sold across state lines in multiple legalize states. Curaleaf is present in 12 US states, including Florida, New York and Oregon, but it also has licensing pending in California and Pennsylvania.

 

 

For a free research report on Chemistree Technology Inc. (CSE: CHM) (OTCQB:CHMJF), visit potstocknews.com.

 

 

Disclaimer:  Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

 

The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated forty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of Chemistree Technology Inc.

 

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PSN and FNM undertake no obligation to update such statements.

 

Media Contact:

FN Media Group, LLC

info@financialnewsmedia.com

+1(561)325-8757

Change in Attorney General Could Mean a Cannabis Revolution in the US

CannabisNewsWire Editorial Coverage 

 

Denver CO – November 29, 2018 –  A new attorney general is still to be named to replace unabashedly anti-cannabis former AG Jeff Sessions. As the market awaits a new AG, there’s a steady push from cannabis companies keeping an eye on the massive potential of the U.S. market, companies that include Chemistree Technology, Inc. (CSE:CHM) (OTC:CHMJF) (Profile), Aurora Cannabis (TSX:ACB) (NYSE:ACB), CannTrust Holdings, Inc. (TSX:TRST), Organigram Holdings, Inc. (TSX.V:OGI) (OTC:OGRMF), and Supreme Cannabis Co. (TSX.V:FIRE) (OTC:SPRWF) (Profile).

 

To view an infographic of this editorial, click here.

 

By the end of 2025, the legal cannabis industry is expected to reach $146.4 billion worldwide. Meanwhile, a good number of U.S. companies and investors are being mostly locked out of this booming market because the federal government still classifies cannabis as a Schedule I drug.

 

However, a sea change of public opinion pointing towards a demand for federal legalization is underway with several states already having voted in favor of cannabis in some form. Even the notoriously conservative, teetotalling state of Utah has joined this revolution.

 

As Sessions’ replacement has yet to be announced, there is ongoing speculation on the positive benefits of a new face for the cannabis sector. As Forbes magazine puts it, “The new AG will likely be less of an opponent for cannabis simply because it is hard to find someone who has stronger opposition than Mr. Sessions.”

 

What’s on the table is a massive multibillion-dollar sector that could be unleashed quite quickly should the next AG have a softer and more populist approach to the plant. During the lead-up to a potential legalization, companies large and small are staking their ground in lucrative U.S. regions already brimming with a willing clientele eager to buy legal cannabis.

 

California alone could bring about a green wave, boasting an existing cannabis market larger than all of Canada combined. Chemistree Technology, Inc. (CSE:CHM) (OTCQB:CHMJF) has already begun setting up shop in the Golden State, having recently solidified a land purchase of 9.55 acres in California’s prominent Desert Hot Springs’ cannabis cultivation zone.

 

Chemistree’s strategic move into California is representative of an early-mover advantage, despite the state’s already booming cannabis sales. California’s cannabis spending hovered near $3 billion in 2017 — even before recreational marijuana became legal on January 1. By 2022, the market in the state is expected to soar to $7.7 billion.

 

In spite of the legal limbo of cannabis in the United States, the sector’s advantage may already be moving south from Canada into its neighbor to the south. Ahead of the new AG announcement, it appears the U.S. opportunity may have already arrived.

 

Waking the American Sleeping Giant

 

Combined, the top U.S. cannabis firms trading on Canadian exchanges represent $8 billion of market value—or roughly 20 percent of the billion-dollar market capitalization of the 144 cannabis companies listed in Canada. This just scratches the surface.

 

At the moment, the United States lags behind its fellow North American peers in fully capitalizing on the legalization of medical and recreational cannabis. Mexico is moving closer to legalization, with its congress at the beginning of deliberation of a bill to legalize cannabis across the country. During his election campaign, Mexican president-elect Andrés Manuel López Obrador signaled his willingness to consider legalization. Then last week, the country’s Supreme Court ruled that anti-cannabis laws are unconstitutional, forcing lawmakers to decide how to regulate its use.

 

To the north, Canada — along with Uruguay in South America — has already made recreational use legal. An additional 30 countries and 33 U.S. states, including Australia, Germany and Israel, have legalized some type of cannabis use. Those numbers are growing. More than a dozen countries have already started on the path to full legalization of the plant.

 

Following the resignation of AG Jeff Sessions, Sessions’ chief of staff, Matthew Whitaker, is presently serving as acting attorney general. Media outlets are speculating who the next AG could be, with New Jersey Governor Chris Christie and Florida AG Pam Bondi leading the way as potential candidates.

 

While Christie has been adamantly anti-pot in the past, Bondi oversaw the approval of medical marijuana in her state of Florida. A Bondi nomination, coupled with strong public support could ultimately be a major boost for the cannabis sector.

 

Gearing Up for a New Era

 

Cannabis companies are already getting their ducks in a row for a new era of legalization. With operations in Washington State and now California, Chemistree is gearing up for a big move.

 

Upon the announcement of its California land acquisition, Chemistree president Karl Kottmeier stated, “This is a great purchase for Chemistree. I am pleased to report that our highly experienced team in California has begun working on this exciting project. Not only did we arrive at what we believe is a very attractive price, we are buying a site that already has much of the Conditional Use Permit application process well underway. We expect to have the application submitted within the next few weeks and anticipate approval to take 2–3 months thereafter.”

 

The property is capable of supporting development plans and a Conditional Use Permit application for three 68,000-square-foot cultivation and processing buildings on the site, totaling approximately 205,000 square feet.

 

Earlier in the year, Chemistree purchased the high-quality, Washington-based Sugarleaf brand with the expressed intent to more than quadruple the reach of its product line through 2019. By taking Sugarleaf’s brand reach across state lines into California, Chemistree is pairing the new brand with its already acquired assets.

 

Beyond cultivation and branding, Chemistree is also expanding into Northern California. The company has entered into a joint venture on a cannabis processing facility in the north, while also seeking capital to expand locations in the state and broaden its service offerings.

 

More Red, White, Blue and Green Opportunities

 

Having recently spun off its American assets into Australis Capital, multinational cannabis producer Aurora Cannabis (TSX:ACB) (NYSE:ACB)  plans to enter the world’s largest economy when relevant laws allow it to do so. While Aurora currently has no direct ownership interest in Australis, the company holds two warrants that would allow it to acquire an ownership interest in Australis if holding investments in U.S. cannabis assets becomes permissible within a decade. In the meantime, Aurora has successfully listed itself on the NYSE.

 

Soon to be following in Aurora’s NYSE footsteps is CannTrust Holdings, Inc. (TSX.V:TRST). CannTrust managed to double its sales in Q3, as it prepared to move to the NYSE. While still early in the game, CannTrust delivered sizeable sales growth, and nominal profits. It entered into supply agreements with nine Canadian provinces to supply recreational cannabis across Canada. The company recently launched its fourth recreational brand named “Peak Leaf,” started shipping cannabis oil to Denmark and entered into an exclusive partnership agreement with Kindred Partners, Inc.

 

Possibly joining the caravan to the NYSE is OrganiGram Holdings, Inc. (TSX.V:OGI) (OTCQX:OGRMF). With a market cap around $600 million, OrganiGram is likely a suitable choice for listing on the NASDAQ exchange, but it could also potentially fit on the NYSE. When it’s finally to scale, OrganiGram will likely be one of the 10 largest cannabis producers in Canada. However, an opening up of the U.S. market would only serve to boost OrganiGram’s already impressive growth curve.

 

While not actively operating in the United States, Supreme Cannabis Co. (TSX:FIRE) (OTCQX:SPRWF) is preparing for entry into the international oils (for medical use) market. Through a partnership with Medigrow located in Lesotho, Supreme is looking to secure international opportunities including Medigrow’s 40,000 litres of cannabis oil potential per year. A loosening of U.S. drug policy could allow groups such as Supreme to import their wares from abroad into the United States and get involved in what could be the largest cannabis market in the world.

 

For more information on Chemistree Technology, Inc. please visit Chemistree Technology, Inc. (CSE:CHM) (OTCQB:CHMJF). Please also read and review the following article, With Cannabis Now Legal in Canada, Investors Are Turning South to the Largest Emerging Cannabis Market in the World.

 

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

 

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

 

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

 

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

 

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN

Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com

Corporate Communications Contact:

CannabisNewsWire (CNW)

Denver, Colorado

www.CannabisNewsWire.com

303.498.7722 Office

Editor@CannabisNewsWire.net

 

Media Contact:

FN Media Group, LLC

NNW@FinancialNewsMedia.com

+1-(954)345-0611

Chemistree partners with Humboldt County, California cannabis processor

VANCOUVER, Nov. 27, 2018 /PRNewswire/ – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Company has entered into a strategic collaboration (the “Collaboration”) with a Humboldt County-based cannabis processing company (the “Processor”) located in Arcata, California. Pursuant to the Collaboration, Chemistree will loan the Processor US$450,000 (the “Loan”), and the parties also intend to negotiate an additional line of credit for working capital purposes. Chemistree expects the Processor will use the proceeds of the loan for business expansion, including to, among other things, purchase additional equipment and make tenant improvements to its facility.

 

Karl Kottmeier, Chemistree’s President, commented “This is a great advancement for Chemistree. Not only is the Processor a highly regarded service provider in the Humboldt cannabis industry, with deep relationships with local cultivators, we believe they are also primed for growth in their sector. We believe that Chemistree can provide capital and management depth to rapidly expand the Processor’s business, both in the local Humboldt area, across the state of California, and ultimately into new jurisdictions across the United States where legal cannabis processing and product development is in formative stages.  Chemistree will also work with the Processor to purchase cannabis biomass on a proprietary basis and process that biomass to ultimately be sold as a Chemistree or Sugarleaf branded product.

 

The Processor holds a “Type 6: Non Volatile Solvent Extraction” license from the State of California.  The Processor uses Apeks super critical CO2 extraction to produce cannabis oil, terpene profiles and other products on behalf of cannabis cultivators, other manufacturers and processors throughout northern California.

 

Chemistree expects to fund the Loan from its existing cash on hand. In addition, in consideration for benefits received by Chemistree under the Collaboration, it has agreed to issue 100,000 common shares to the principal of the Processor.

 

Additionally, Chemistree is pleased to announce it has engaged Native Ads to provide, manage and consult on a wide variety of marketing and digital marketing initiatives for the company.

 

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. and international cannabis sector, providing turn key solutions for the regulated cannabis industry.  The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities.  The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a first investment in the Canadian cannabis sector through Pasha Brands and has a robust pipeline of assets to grow its base of business.  For more information,

visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

 

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

 

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

 

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Form 2A listing statement filed with the CSE and the Company’s annual information form available under its profile on SEDAR at www.sedar.com.

 

“Karl Kottmeier”
President

 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

 

Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, “budget”, “scheduled” and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about adding clients, building on the Company’s initial product offerings, negotiation of a line of credit for working capital purposes with the Processor, the expected uses of the Loan proceeds by the Processor, growth and expansion of the Processor’s business, and the benefits to Chemistree of the Collaboration. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators, including under the heading “Risk Factors” in its annual information form dated September 28, 2018 for the fiscal year ended June 30, 2018 available under the Company’s profile on SEDAR at www.sedar.com.  Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

 

 

SOURCE Chemistree Technology Inc.

Chemistree to sponsor High Times event featuring 50 Cent at MJBizCon in Las Vegas

VANCOUVER, Nov. 14, 2018 /PRNewswire/ – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce its sponsorship of the upcoming High Times “Biz Bash” party, featuring 50 Cent during the MJBizCon Conference and Expo, the premier marijuana business conference in North America. The Biz Bash will be held on Thursday, November 15, 2018 at the Brooklyn Bowl, Las Vegas, Nevada at 8pm.

 

The sponsorship of High Times and the recent launch of the new Sugarleaf website is part of an aggressive marketing and sale campaign to introduce Chemistree Technology to all cannabis retailers starting with over 3,300 retail dispensaries and cultivation with the majority located in California, Colorado, Arizona and Nevada.

 

Jeremy Deichen of Chemistree commented, “it is our pleasure to team with our friends at High Times to pull-off this amazing event. In working with them over the years with “Growing Exposed” we have learned that they are truly the masters at getting eyeballs on what is new and fresh in the industry”.

 

About High Times

For more than 40 years, High Times has been the authoritative voice of authentic cannabis culture, leading the fight for legalization and empowering the burgeoning industry’s legal entrepreneurs. High Times content spans digital, social, video and print platforms as well as location-based events highlighted by the Cannabis Cup global franchise and the High Times Business Summit conference series. Visit us at HighTimes.com, and follow @HIGH_TIMES_Mag on Twitter, @hightimesmagazine on Instagram or like us on Facebook at: https://www.facebook.com/HIGHTIMESMag/

 

About MJBizCon:

MJBizDaily’s flagship event, MJBizCon, is the preeminent conference to drive business deals and forge valuable connections with cannabis professionals in business today. Don’t miss the largest cannabis conference in the world, where business ideas become business deals. Join 20,000+ cannabis professionals, 1,000+ exhibitors and the GCAC executive team at the largest event of its kind, hosted at the Las Vegas Convention Centre, on November 14 – 16, 2018. For more information: www.mjbizconference.com.

 

About Chemistree Technology Inc.

Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, providing turn key solutions for the U.S. regulated cannabis industry.  The Company’s corporate strategy is to acquire and develop vertically integrated U.S. cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities throughout the U.S.  The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California and a first investment in the Canadian cannabis sector through Pasha Brands, and it has a robust pipeline of assets to grow its base of business.  For more information, visit www.chemistree.ca.

 

Advisory

The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

 

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

 

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

 

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Form 2A listing statement filed with the CSE.

 

“Karl Kottmeier”
President

 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

 

Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, “budget”, “scheduled” and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about adding clients, building on the Company’s initial product offerings, entry into of definitive agreements. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators.  Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

 

 

SOURCE Chemistree Technology Inc.

About Chemistree Technology

Chemistree Technology Inc. is an investment company dedicated to the U.S. and international cannabis sector, providing turn key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a first investment in the Canadian cannabis sector through Pasha Brands and has a robust pipeline of assets to grow its base of business.

 

The Company believes the cannabis industry offers a tremendous opportunity for growth.

 

The reason for this is simply that marketing of cannabis companies, their products as well as information about the industry itself is in its infancy.Initially, the Pacific Northwest is the Company’s main target geography, but this is expected to expand from British Columbia and Washington into Oregon, and eventually California.

 

Chemistree Development Plans

 

 

investmentINVESTMENT

 

Through our continually expanding portfolio of brands and hard assets Chemistree will  provide a public vehicle entity to investors who are looking to invest in a company that is vertically integrated and approaches the Cannabis and CBD industry from a United States Market perspective.

 

 

partnershipJOINT VENTURE

 

From a Chemistree perspective, Joint Ventures agreement with Industry Players provides the Company with a secure, and predictable source of incremental cannabis supply, increased diversification of its products and Brands available for sale, and an ideal partner to generate referral and introduction opportunities for Chemistree’s platforms.

 

 

Development Plans

 

 

 

From our CEO

 

We are at a historical turning point – the end of a prohibition. Very rarely, maybe once in a life time will anyone get an opportunity like this.

 

The epicentre of this opportunity will be California and Chemistree has already established itself as a multifaceted player in that market.

 

Come join us in this growth story.    KARL KOTTMEIER

 

Source:  http://chemistree.ca/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated twenty one hundred dollars for Chemistree Technology Inc. current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Chemistree Technology Inc.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Sign Up & Get FREE News Alerts From FNM Today!